Intelligent Bio Solutions

Intelligent Bio Solutions Market capitalization

The The market capitalization of Intelligent Bio Solutions (INBS) as of Nov 3, 2026 is 5.52 M USD. In the previous year, The market capitalization was 5.52 M USD — a change of 0.00% (lower).

Market capitalization

5.52 MUSD

YoY

0.00%

Last updated:

In 2026, Intelligent Bio Solutions's market cap stood at 5.52 M USD, a 0.00% increase from the 5.52 M USD market cap in the previous year.

The Intelligent Bio Solutions Market capitalization history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Market capitalization
Date
Market capitalization
Jan 1, 2019
5.52 M USD
Jan 1, 2020
5.52 M USD
Jan 1, 2021
5.52 M USD
Jan 1, 2022
5.52 M USD
Jan 1, 2023
5.52 M USD
Jan 1, 2024
5.52 M USD
Jan 1, 2025
5.52 M USD
Jan 1, 2026
5.52 M USD
The Intelligent Bio Solutions Market capitalization history
YEARMarket capitalizationYoY
5.52 MUSD0.00%
5.52 MUSD0.00%
5.52 MUSD0.00%
5.52 MUSD0.00%
5.52 MUSD0.00%
5.52 MUSD0.00%
5.52 MUSD0.00%
5.52 MUSD0.00%
5.52 MUSD0.00%
5.52 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Intelligent Bio Solutions Stock analysis

What does Intelligent Bio Solutions do? Intelligent Bio Solutions, Inc. generates revenue through its Commercially available Intelligent Fingerprinting Products (IFPG) segment, which includes a portable drug screening system analyzing fingerprint sweat via a one-time cartridge and handheld reader. The company also develops diagnostic tests under the Development Stage Saliva Glucose Biosensor Platform (SGBP), targeting diabetic patients with a non-invasive saliva glucose biosensor (SGB) intended to replace finger-prick blood monitoring. Its biosensor platform supports multiple biological analyte detection for point-of-care diagnostic tests (POCT) in clinical chemistry, immunology, tumor markers, allergens, and endocrinology. The firm serves primary health practitioners and patients seeking non-invasive monitoring solutions. The company's product portfolio features the IFPG segment's portable drug screening system, which is sold to healthcare providers and law enforcement agencies for rapid drug testing. The SGBP segment focuses on developing the Saliva Glucose Biosensor (SGB), a point-of-care diagnostic test expected to address the needs of diabetic patients requiring frequent glucose monitoring without invasive procedures. The biosensor platform enables detection of multiple analytes, expanding the company's offerings in clinical chemistry and related diagnostic fields. Intelligent Bio Solutions, Inc. targets primary health practitioners and patients as key segments for its non-invasive diagnostic solutions. The IFPG segment's portable drug screening system is designed for use in clinical and law enforcement settings, while the SGBP segment's Saliva Glucose Biosensor aims to provide a convenient alternative to traditional blood glucose monitoring for diabetic patients. The company's development stage products focus on replacing invasive methods with real-time, non-invasive monitoring technologies. Intelligent Bio Solutions is one of the most popular companies on Eulerpool.

Market capitalization Details

Exploring Intelligent Bio Solutions's Market Capitalization

Intelligent Bio Solutions's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Intelligent Bio Solutions's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Intelligent Bio Solutions's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Intelligent Bio Solutions’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Intelligent Bio Solutions stock

The market capitalization of Intelligent Bio Solutions is 5.52 M USD in 2026.

The market capitalization of Intelligent Bio Solutions changed from 5.52 M USD to 5.52 M USD, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The market capitalization Intelligent Bio Solutions since 2006 – with annual values, charts, and detailed analysis.

Market capitalization (German: Market capitalization, English: market capitalisation or market cap) is the calculated total value of all shares of a publicly traded company. The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company. It is determined by the supply and demand for the company's shares. Thus, market capitalization is significantly influenced by expectations in the stock market regarding the future earnings power of the company and, therefore, can be subject to significant fluctuations.

Number of shares * share price = market capitalization

To evaluate The market capitalization's USD, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for The market capitalization.

A 'good' USD varies by industry and company stage. On Eulerpool, you can compare The market capitalization's Intelligent Bio Solutions with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Intelligent Bio Solutions

All Key Metrics — Intelligent Bio Solutions